Real-World Study in Patients With ALK plus Metastatic Non-Small Cell Lung Cancer (mNSCLC) Treated With First-Line (1L) Lorlatinib

Authors

• Shirish M. Gadgeel, Henry Ford HealthFollow
• L. Stansfield
• P. Ramachandran
• O. Emidio
• A. Kotomale
• N. Rifi
• L. Alejandro
• D. Abrahami

Recommended Citation

Gadgeel SM, Stansfield L, Ramachandran P, Emidio O, Kotomale A, Rifi N, Alejandro L, Abrahami D. Real-World Study in Patients With ALK plus Metastatic Non-Small Cell Lung Cancer (mNSCLC) Treated With First-Line (1L) Lorlatinib. J Thorac Oncol 2025; 20(10):1.

Document Type

Conference Proceeding

Publication Date

10-1-2025

Publication Title

J Thorac Oncol

Keywords

non-small cell lung cancer, real world, lorlatinib, Oncology, Respiratory System

Volume

20

Issue

10

First Page

1